Radius Health Inc (NASDAQ:RDUS)
| 10.47 Delayed Data As of Jun 28 |  +0.32 / +3.14%Today’s Change | 4.97 Today|||52-Week Range 23.00 | +51.30% Year-to-Date |
Latest RDUS News | Press Releases
| Radius (RDUS) to Go Private With $890M Deal, Shares Gain Jun 24 / Zacks.com - Paid Partner Content | Radius (RDUS), Menarini Submit NDA for Breast Cancer Drug Jun 23 / Zacks.com - Paid Partner Content |
| Why Radius Health Climbed Today Jun 23 / MotleyFool.com - Paid Partner Content |
Today’s Trading
| Previous close | 10.18 |
| Today’s open | 10.15 |
| Day’s range | 10.11 - 10.52 |
| Volume | 2,928,398 |
| Average volume (3 months) | 1,083,961 |
| Market cap | $481.2M |
Data as of 4:00pm ET, 06/28/2022
Growth & Valuation
| Earnings growth (last year) | +36.77% |
| Earnings growth (this year) | +98.55% |
| Earnings growth (next 5 years) | +50.00% |
| Revenue growth (last year) | -3.63% |
| P/E ratio | NM |
| Price/Sales | 1.42 |
| Price/Book | -- |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| ANIPANI Pharmaceuticals ... | -1.22 | -4.04% |
| KZRKezar Life Sciences ... | +2.51 | +43.43% |
| AGENAgenus Inc | -0.04 | -2.13% |
| ALTAltimmune Inc | -0.11 | -0.94% |
Data as of 7:56pm ET, 06/28/2022
Financials
| Next reporting date | August 4, 2022 |
| EPS forecast (this quarter) | $0.09 |
| Annual revenue (last year) | $230.0M |
| Annual profit (last year) | -$70.2M |
| Net profit margin | -30.51% |
Profile
Sector Health Technology |
Industry Biotechnology |
No executives to display |
Corporate headquarters Boston, Massachusetts |
Forecasts
